PALO ALTO, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Excellergy, a biotechnology company developing a new class of allergy therapeutics, today announced its launch with a $70 million Series A ...
The LaBrants capture their daughter's reaction as she takes a pregnancy test. Senator, brother, officer indicted in federal extortion, conspiracy case Scientists Studied 'SuperAgers' For 25 Years And ...